Pliant Therapeutics (PLRX)
NASDAQ:PLRX
Holding PLRX?
Track your performance easily

Pliant Therapeutics (PLRX) Financial Statements

424 Followers

Pliant Therapeutics Financial Overview

Pliant Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.342; its P/E ratio is -4.49; Pliant Therapeutics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.99. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue----$ 248.00K
Gross Profit----$ 248.00K
EBIT$ -57.76M$ -55.85M$ -40.79M$ -41.17M$ -40.87M
EBITDA$ -56.35M$ -55.20M$ -40.32M$ -40.72M$ -37.26M
Net Income Common Stockholders$ -57.76M$ -60.64M$ -41.11M$ -41.49M$ -47.33M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 404.51M$ 436.61M$ 494.25M$ 523.61M$ 555.16M
Total Assets$ 445.67M$ 483.73M$ 512.15M$ 540.46M$ 574.89M
Total Debt$ 60.21M$ 60.23M$ 11.37M$ 12.08M$ 14.54M
Net Debt$ -344.30M$ -376.38M$ -482.87M$ -511.53M$ -540.62M
Total Liabilities$ 99.84M$ 91.05M$ 38.58M$ 37.42M$ 41.83M
Stockholders Equity$ 345.82M$ 392.68M$ 473.58M$ 503.05M$ 533.07M
Cash Flow-
Free Cash Flow$ -33.17M$ -46.55M$ -25.16M$ -36.32M$ -25.36M
Operating Cash Flow$ -32.27M$ -45.30M$ -25.10M$ -36.22M$ -24.76M
Investing Cash Flow$ 30.96M$ 10.70M$ 31.92M$ 38.25M$ -22.98M
Financing Cash Flow$ 543.00K$ 684.00K$ 219.00K$ 699.00K$ 161.00K
Currency in USD

Pliant Therapeutics Earnings and Revenue History

Pliant Therapeutics Debt to Assets

Pliant Therapeutics Cash Flow

Pliant Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis